Ospedale San Giovanni di Dio

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Chronic kidney disease
• IgA nephropathy

Running trials

• Active, not recruiting

  Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

  NCT06291376· Phase 3· Alexion Pharmaceuticals, Inc.· Source